13th Congress of the Asian Society of Transplantation: Advances in Kidney Transplantation
Case Report
Cryptococcal Necrotizing Fasciitis in a Patient After Renal Transplantation—A Case Report

https://doi.org/10.1016/j.transproceed.2013.11.034Get rights and content

Abstract

A 50-year-old man, who had received an ABO-incompatible living related preemptive renal transplantation 1 year before, presented with painful lesions on both lower extremities and fever. At first, bacterial cellulitis was suspected and antibiotic therapy was initiated, but it was not effective. The serum cryptococcal antigen titer was 1:4,098, and pathologic examination of debrided tissue and wound pus culture revealed cryptococcal necrotizing fasciitis. Liposomal amphotericin B and fluconazole were started, and repeated debridement and skin grafting were performed. Because his graft function deteriorated because of antibody-mediated rejection and polyoma viral nephropathy, hemodialysis was induced on day 9 of hospitalization. During the treatment, he suffered repeated urinary tract infections, which were treated with antibiotics, and cytomegalovirus retinopathy, which was treated with ganciclovir. His cryptococcal necrotizing fasciitis was successfully cured by the combination of antimicrobial treatment and surgical procedures. He could walk with a cane and was discharged on day 298 of hospitalization. Cryptococcal necrotizing fasciitis in renal transplant recipients is so rare that only 14 cases have been reported. The mortality is not very high, but the prognosis of the patient is complicated by worsening of the cryptococcal infection of the central nervous system (CNS). Early detection and treatment to prevent spreading to other sites, especially the CNS or disseminated disease, is very important in cases of cryptococcal necrotizing fasciitis.

Section snippets

Case Report

A 50-year-old man, who had received a living related preemptive renal transplantation for polycystic kidney disease one year before, presented with painful lesions on both lower extremities and fever. Bacterial cellulitis was suspected and he was hospitalized. Because he had received an ABO-incompatible renal transplantation, double-filtration plasma pheresis and plasma exchange were performed and rituximab was used before the transplantation. Induction immunosuppressants were basiliximab,

Discussion

Cryptococcosis is the third most frequently invasive fungal infection after candidiasis and aspergillosis in organ transplant recipients [2]. The incidence of cryptococcal disease in organ transplant recipients in an earlier cohort (1952–2002) did not differ from that in a more recent cohort (2003–2010), but in renal transplant recipients the incidence in the earlier cohort was higher than that in the recent cohort [3]. The time to onset of cryptococcal disease after transplantation was

References (17)

  • S. Husan et al.

    Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome

    Emerg Infect Dis

    (2003)
  • R.A. Vilchez et al.

    Cryptococcosis in organ transplant recipients: an overview

    Am J Transplant

    (2004)
  • H.Y. Sun et al.

    Cryptococcosis in solid-organ, hematopoietic stem cell and tisuue transplant recipients: evidence-based evolving trends

    Clin Infect Dis

    (2011)
  • N. Singh et al.

    Crptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality

    J Infect Dis

    (2009)
  • N. Singh et al.

    AST Infectious Disease Community of Practice. Cryptococcosis in solid organ transplant recipients

    Am J Transplant

    (2011)
  • J.R. Perfect et al.

    Clinical practice guidelines for the management of cryptococcal disease: 2012 update by the infectius disease society of America

    Clin Infect Dis

    (2012)
  • C.R. McHenry et al.

    Determinants of mortality for necrotizing soft-tisduue infections

    Ann Surg

    (1997)
  • S.K. Shrader et al.

    Disseminated cryptococcosis presenting as cellulitis with necrotizing vasculitis

    J Clin Microbiol

    (1988)
There are more references available in the full text version of this article.

Cited by (0)

View full text